2014
DOI: 10.1007/s15010-014-0685-2
|View full text |Cite
|
Sign up to set email alerts
|

Risk factor for death in hematopoietic stem cell transplantation: are biomarkers useful to foresee the prognosis in this population of patients?

Abstract: Out of the biomarkers assessed, only CRP ≥ 120 mg/L was independently associated with death. Other risk factors found were: type of transplantation (allogeneic and unrelated), bloodstream infection by Gram-negative, LDH ≥ 390 UI/L and urea ≥ 25 mg/dL. For allogeneic patients only CRP ≥ 120 mg/L and BSI due to Gram-negative were risk factors for death; however, CRP did not remain in the model when urea ≥ 25 mg/L was included.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
9
0
5

Year Published

2016
2016
2024
2024

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 21 publications
(15 citation statements)
references
References 28 publications
1
9
0
5
Order By: Relevance
“…Ней-тропеническая лихорадка (НЛ) -самое частое прояв-ление инфекционного процесса у больных после ВДХТ и аутоТГСК. Частота этого осложнения составляет 64,2-79,0 % [2][3][4]. Локализованная инфекция, сепсис и септический шок встречаются значительно реже [4].…”
Section: Introductionunclassified
See 2 more Smart Citations
“…Ней-тропеническая лихорадка (НЛ) -самое частое прояв-ление инфекционного процесса у больных после ВДХТ и аутоТГСК. Частота этого осложнения составляет 64,2-79,0 % [2][3][4]. Локализованная инфекция, сепсис и септический шок встречаются значительно реже [4].…”
Section: Introductionunclassified
“…Это прежде всего тип трансплантации: при аллогенной, особенно неродственной, риск летального исхода, в т. ч. связанного с инфекцией, значимо выше [4]. По-жилой возраст также относится к отягощающим фак-торам [4].…”
Section: Introductionunclassified
See 1 more Smart Citation
“…[5][6][7] As a 116-amino-acid peptide typically produced in the thyroid, systemic production is substantially increased in the setting of microbial infection 8,9 and higher levels may be associated with more severe disease or sepsis. 10 Evaluation of procalcitonin in the setting of allogeneic HSCT is limited, [11][12][13] with no data regarding its role in the setting of ES. A clinical utility of using procalcitonin in oncology in general is demonstrated.…”
Section: Introductionmentioning
confidence: 99%
“…e Pseudomonas aeruginosa, em decorrência do aumento do uso profilático de fluorquinolonas. (38)(39)(40)(41) A bactéria gram positiva mais prevalente é o…”
Section: Epidemiologia E Impacto Da Neutropenia Febrilunclassified